Neuromed
ActiveThe computed 12-month bankruptcy probability of Neuromed is 2.3% (moderate). The 2025 annual accounts show equity of €120k and a net result of €118k. Equity is growing by ~61.5% per year across the filed fiscal years. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
100
/ 100
Excellent= vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency99▼-1
Growth78=
Stability94
Bankruptcy probability, 12 months
2.3%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €12k at 30 days acceptable
Liquidity ample (current ratio 2.54 against 3.8 in 2024), and 38.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
61.2%
Return on assets
59.9%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
8 d early
2024
7 d early
2023
23 d early
2022
6 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€120k▲ 28.2%
2024 · €94k
2022: €10k
2023: €34k
2024: €94k
2022 → 2025
Total assets
€197k▲ 38.6%
2024 · €142k
2022: €14k
2023: €82k
2024: €142k
2022 → 2025
Net result
€118k▲ 93.6%
2024 · €61k
2022: €8k
2023: €25k
2024: €61k
2022 → 2025
Working capital
€107k▲ 29.1%
2024 · €83k
2022: €10k
2023: €23k
2024: €83k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€10k-€34k▲ 232%€94k▲ 177%€120k▲ 28.2%
Operating result€10k-€34k▲ 243%€79k▲ 132%€154k▲ 95.2%
Net result€8k-€25k▲ 217%€61k▲ 148%€118k▲ 93.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen three years in a row; 2025 is 95% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €197k
Fixed assets
€21k▼ 30.2%
Current assets
€176k▲ 57.0%
Equity and liabilities €197k
Equity
€120k▲ 28.2%
Debt
€76k▲ 59.2%
The debt ratio rises from 33.8% to 38.8%: debt grows faster than equity.
Key figures and ratios
EBITDA
€166k▲
2024 · €90k
Cash flow
€130k▲
2024 · €72k
Solvency
61.2%▼
2024 · 66.2%
Current ratio
2.54▼
2024 · 3.80
Quick ratio
2.54▼
2024 · 3.80
Debt / equity
0.63▲
2024 · 0.51
ROE
97.8%▲
2024 · 64.8%
ROA
59.9%▲
2024 · 42.9%
Interest coverage
111.45▲
2024 · 43.71
Debt
€76k▲
2024 · €48k
Debt ≤ 1 year
€69k▲
2024 · €29k
Debt > 1 year
€7k▼
2024 · €18k
Income taxes
€40k▲
2024 · €18k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€142k€197k▲
Fixed assets21/28€30k€21k▼
Tangible fixed assets22/27€30k€20k▼
Furniture and vehicles24€30k€20k▼
Financial fixed assets28-€840
Current assets29/58€112k€176k▲
Amounts receivable within one year40/41€66k€134k▲
Trade receivables40€4k€1k▼
Other amounts receivable41€62k€132k▲
Current investments50/53-€7k
Cash at bank and in hand54/58€46k€35k▼
Deferred charges and accrued income490/1€0-
Equity and liabilities
Total equity and liabilities10/49€142k€197k▲
Equity10/15€94k€120k▲
Contributions10/11€3k€3k=
Reserves13€91k€118k▲
Distributable reserves133€91k€118k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€48k€76k▲
Amounts payable after more than one year17€18k€7k▼
Financial debts170/4€18k€7k▼
Amounts payable within one year42/48€29k€69k▲
Current portion of amounts payable after more than one year42€11k€11k▲
Trade debts44€506€51▼
Suppliers440/4€506€51▼
Taxes, remuneration and social security45€18k€58k▲
Taxes450/3€18k€58k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11k€12k▲
Other operating charges640/8€775€547▼
Gross operating margin9900€91k€167k▲
Operating profit (loss)9901€79k€154k▲
Financial income75/76B€2k€5k▲
Recurring financial income75€2k€5k▲
Financial charges65/66B€2k€1k▼
Recurring financial charges65€2k€1k▼
Profit (loss) for the period before taxes9903€79k€158k▲
Income taxes67/77€18k€40k▲
Profit (loss) for the period9904€61k€118k▲
Profit (loss) for the period to be appropriated9905€61k€118k▲
Appropriation of the result
Profit (loss) to be appropriated9906€61k€118k▲
Transfer from equity791/2€833€91k▲
Transfer to equity691/2€61k€118k▲
To other reserves6921€61k€118k▲
Profit to be distributed694/7€833€91k▲
Return on contributions (dividend)694€833€91k▲
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2022net €118k ▲93.6%
Operating result €154k, net result €118k, both a record.
31-12
Financial
Equity above €100kEq €120k ▲28.2%
4 profitable years in a row build equity to €120k.
24-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
08-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
25-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schoten · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Wezelsebaan 2282900 SchotenGround area
2,146 m²
Building footprint
229 m²
Volume, LiDAR
1,528 m³
Parcel 11040D0149/02F003, Flanders · tallest building 11.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Neuromed
since 20222.335.238.871
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11040D0149/02F003 | Flanders | 2,146 m² | 1 · 229 m² | 11.5 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded01-09-2022
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.